Chemotherapy in Small Cell Lung Cancer with End-Stage Renal Disease on Hemodialysis.
10.12771/emj.2014.37.S.S5
- Author:
Sang Il CHOI
1
;
Sun Seob PARK
;
Eun Jeong KO
;
Si Won LEE
;
Mihong CHOI
;
Kiwon KIM
Author Information
1. Department of Internal Medicine, National Cancer Center, Goyang, Korea. kiwonkim@ncc.re.kr
- Publication Type:Case Report
- Keywords:
Small cell lung carcinoma;
Drug therapy;
Kidney failure, chronic;
Renal dialysis
- MeSH:
Consensus;
Drug Therapy*;
Humans;
Kidney Failure, Chronic*;
Renal Dialysis*;
Small Cell Lung Carcinoma*
- From:The Ewha Medical Journal
2014;37(Suppl):S5-S9
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Small cell lung cancer is primarily treated with chemotherapy. For patients with end-stage renal disease (ESRD), systemic chemotherapy is often challenging since renal excretion of chemotherapeutic agents might be decreased due to impaired renal function, leading to increased toxicity. No consensus is made so far regarding appropriate dosage and combination of chemotherapeutic agents for patients on hemodialysis. We report two cases of chemotherapy without significant toxicity in small cell lung cancer patients who were on hemodialysis for ESRD.
